Dianthus Therapeutics (DNTH) PT Raised to $130 at Clear Street
Clear Street analyst Bill Maughan raised the price target on Dianthus Therapeutics (NASDAQ: DNTH) to $130.00 (from $100.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
